136 related articles for article (PubMed ID: 32017698)
21. Ependymosarcoma harboring C11orf95:RELA fusion transcript: Report of two cases and review of the literature.
Mahajan S; Nambirajan A; Sharma A; Suri V; Sardana H; Phalak M; Garg A; Sharma MC
Neuropathology; 2021 Oct; 41(5):412-421. PubMed ID: 34558124
[TBL] [Abstract][Full Text] [Related]
22. Sarcomatous Change of Cerebellopontine Angle Ependymoma Following Radiosurgery: A Case Report.
Dadario NB; Pruitt R; Silverstein JW; Zlochower A; Teckie S; Harshan M; D'Amico RS
Cureus; 2022 Jan; 14(1):e20864. PubMed ID: 35145771
[TBL] [Abstract][Full Text] [Related]
23. [Surgical seeding of an anaplastic ependymoma].
Yamada M; Sato T; Kuromi Y; Matsumoto Y; Oda K; Kishida Y; Tamura T; Ichikawa M; Sakuma J; Saito K
No Shinkei Geka; 2013 Dec; 41(12):1093-7. PubMed ID: 24317886
[TBL] [Abstract][Full Text] [Related]
24. A case of anaplastic clear-cell ependymoma presenting with high erythropoietin concentration and 1p/19q deletions.
Asano K; Kudo K; Mori F; Ohkuma H; Wakabayashi K
Brain Tumor Pathol; 2011 Oct; 28(4):317-27. PubMed ID: 21643803
[TBL] [Abstract][Full Text] [Related]
25. Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1.
Kraus JA; de Millas W; Sörensen N; Herbold C; Schichor C; Tonn JC; Wiestler OD; von Deimling A; Pietsch T
Acta Neuropathol; 2001 Jul; 102(1):69-74. PubMed ID: 11547953
[TBL] [Abstract][Full Text] [Related]
26. Gliosarcoma with chondroblastic osteosarcomatous differentation: report of two case with clinicopathologic and immunohistochemical features.
Barut F; Kandemir NO; Ozdamar SO; Gul S; Bektas S; Gun BD; Bahadir B
Turk Neurosurg; 2009 Oct; 19(4):417-22. PubMed ID: 19847765
[TBL] [Abstract][Full Text] [Related]
27. Expression profiling of ependymomas unravels localization and tumor grade-specific tumorigenesis.
Palm T; Figarella-Branger D; Chapon F; Lacroix C; Gray F; Scaravilli F; Ellison DW; Salmon I; Vikkula M; Godfraind C
Cancer; 2009 Sep; 115(17):3955-68. PubMed ID: 19536879
[TBL] [Abstract][Full Text] [Related]
28. Clear cell ependymoma: a clinicopathologic and radiographic analysis of 10 patients.
Fouladi M; Helton K; Dalton J; Gilger E; Gajjar A; Merchant T; Kun L; Newsham I; Burger P; Fuller C
Cancer; 2003 Nov; 98(10):2232-44. PubMed ID: 14601094
[TBL] [Abstract][Full Text] [Related]
29. Anaplastic ependymomas: clinical features and tumour suppressor gene p53 analysis.
Tominaga T; Kayama T; Kumabe T; Sonoda Y; Yoshimoto T
Acta Neurochir (Wien); 1995; 135(3-4):163-70. PubMed ID: 8748809
[TBL] [Abstract][Full Text] [Related]
30. Expression of a restrictive receptor for interleukin 13 is associated with glial transformation.
Debinski W; Slagle B; Gibo DM; Powers SK; Gillespie GY
J Neurooncol; 2000 Jun; 48(2):103-11. PubMed ID: 11083073
[TBL] [Abstract][Full Text] [Related]
31. Merlin expression in pediatric anaplastic ependymomas real time PCR study.
Buccoliero AM; Castiglione F; Rossi Degl'Innocenti D; Sardi I; Genitori L; Taddei GL
Fetal Pediatr Pathol; 2010; 29(4):245-54. PubMed ID: 20594149
[TBL] [Abstract][Full Text] [Related]
32. Molecular genetic alterations on chromosomes 11 and 22 in ependymomas.
Lamszus K; Lachenmayer L; Heinemann U; Kluwe L; Finckh U; Höppner W; Stavrou D; Fillbrandt R; Westphal M
Int J Cancer; 2001 Mar; 91(6):803-8. PubMed ID: 11275983
[TBL] [Abstract][Full Text] [Related]
33. Molecular genetics of ependymoma.
Yao Y; Mack SC; Taylor MD
Chin J Cancer; 2011 Oct; 30(10):669-81. PubMed ID: 21959044
[TBL] [Abstract][Full Text] [Related]
34. Influence of tumor grade on time to progression after irradiation for localized ependymoma in children.
Merchant TE; Jenkins JJ; Burger PC; Sanford RA; Sherwood SH; Jones-Wallace D; Heideman RL; Thompson SJ; Helton KJ; Kun LE
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):52-7. PubMed ID: 12007941
[TBL] [Abstract][Full Text] [Related]
35. Expression of N-ras gene in gliomas.
Tsurushima H; Tsuboi K; Yoshii Y; Ohno T; Meguro K; Nose T
Neurol Med Chir (Tokyo); 1996 Oct; 36(10):704-8. PubMed ID: 8937091
[TBL] [Abstract][Full Text] [Related]
36. Novel fusion genes and chimeric transcripts in ependymal tumors.
Olsen TK; Panagopoulos I; Gorunova L; Micci F; Andersen K; Kilen Andersen H; Meling TR; Due-Tønnessen B; Scheie D; Heim S; Brandal P
Genes Chromosomes Cancer; 2016 Dec; 55(12):944-953. PubMed ID: 27401149
[TBL] [Abstract][Full Text] [Related]
37. EphB2 activation is required for ependymoma development as well as inhibits differentiation and promotes proliferation of the transformed cell.
Chen P; Rossi N; Priddy S; Pierson CR; Studebaker AW; Johnson RA
Sci Rep; 2015 Mar; 5():9248. PubMed ID: 25801123
[TBL] [Abstract][Full Text] [Related]
38. Systemic metastases from central nervous system ependymoma: case report and review of the literature.
Marsecano C; Bruno F; Michelini G; Perri M; Calvisi G; Di Cesare E; Splendiani A
Neuroradiol J; 2017 Jun; 30(3):274-280. PubMed ID: 28627990
[TBL] [Abstract][Full Text] [Related]
39. Familial anaplastic ependymoma: evidence of loss of chromosome 22 in tumour cells.
Nijssen PC; Deprez RH; Tijssen CC; Hagemeijer A; Arnoldus EP; Teepen JL; Holl R; Niermeyer MF
J Neurol Neurosurg Psychiatry; 1994 Oct; 57(10):1245-8. PubMed ID: 7931388
[TBL] [Abstract][Full Text] [Related]
40. TERT Promoter Mutations but not the Alternative Lengthening of Telomeres Phenotype Are Present in a Subset of Ependymomas and Are Associated With Adult Onset and Progression to Ependymosarcoma.
Brügger F; Dettmer MS; Neuenschwander M; Perren A; Marinoni I; Hewer E
J Neuropathol Exp Neurol; 2017 Jan; 76(1):61-66. PubMed ID: 28040793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
